Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Sonrotoclax Combined Regimen in t(11;14) AL Amyloidosis
NCT07335887Phase 2Recruiting
- Sponsor
- Peking University People's Hospital
- Start
- Feb 2026
- Primary completion
- Dec 2027
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 2 trial of sonrotoclax in amyloid light chain amyloidosis, sponsored by Peking University People's Hospital. Started Feb 2026; status: recruiting.
02
Drugs
sonrotoclax
03
Conditions
amyloid light chain amyloidosis
Beyond the preview
Go deeper on NCT07335887.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07335887.